These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34281219)

  • 1. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
    Ottaviano M; Giunta EF; Rescigno P; Pereira Mestre R; Marandino L; Tortora M; Riccio V; Parola S; Casula M; Paliogiannis P; Cossu A; Vogl UM; Bosso D; Rosanova M; Mazzola B; Daniele B; Palmieri G; Palmieri G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of
    Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
    Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
    J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers of cisplatin resistance in advanced testicular germ cell tumours.
    García-Velasco A; Durán I; García E; Tarón M; Ballestín C; Castellanos D; Cortés-Funés H; Paz-Ares L
    Clin Transl Oncol; 2012 Jun; 14(6):452-7. PubMed ID: 22634534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation.
    Houldsworth J; Xiao H; Murty VV; Chen W; Ray B; Reuter VE; Bosl GJ; Chaganti RS
    Oncogene; 1998 May; 16(18):2345-9. PubMed ID: 9620551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic evolution and chemoresistance in germ-cell tumours.
    Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
    Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms behind the resistance of cisplatin in germ cell tumours.
    Piulats JM; Jiménez L; García del Muro X; Villanueva A; Viñals F; Germà-Lluch JR
    Clin Transl Oncol; 2009 Dec; 11(12):780-6. PubMed ID: 20045784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The component of the m
    Miranda-Gonçalves V; Lobo J; Guimarães-Teixeira C; Barros-Silva D; Guimarães R; Cantante M; Braga I; Maurício J; Oing C; Honecker F; Nettersheim D; Looijenga LHJ; Henrique R; Jerónimo C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):268. PubMed ID: 34446080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
    Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms.
    Skowron MA; Vermeulen M; Winkelhausen A; Becker TK; Bremmer F; Petzsch P; Schönberger S; Calaminus G; Köhrer K; Albers P; Nettersheim D
    Br J Cancer; 2020 Aug; 123(3):378-391. PubMed ID: 32418994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular events in germ cell tumours: linking chromosome-12 gain, acquisition of pluripotency and response to cisplatin.
    Korkola JE; Houldsworth J; Bosl GJ; Chaganti RS
    BJU Int; 2009 Nov; 104(9 Pt B):1334-8. PubMed ID: 19840009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.
    De Giorgi U; Yuan J; Moroni M; Veronese S; Sartore-Bianchi A; Broggini M; Rosti G; Strebhardt K; Ruffini PA
    Int J Biol Markers; 2015 Jul; 30(3):e275-81. PubMed ID: 25982682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors.
    Feldman DR; Iyer G; Van Alstine L; Patil S; Al-Ahmadie H; Reuter VE; Bosl GJ; Chaganti RS; Solit DB
    Clin Cancer Res; 2014 Jul; 20(14):3712-20. PubMed ID: 24812411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
    Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
    Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
    Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry.
    Fichtner A; Bohnenberger H; Elakad O; Richter A; Lenz C; Oing C; Ströbel P; Kueffer S; Nettersheim D; Bremmer F
    World J Urol; 2022 Feb; 40(2):373-383. PubMed ID: 35084545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.